Skip to main content
eScholarship
Open Access Publications from the University of California

UCLA

UCLA Previously Published Works bannerUCLA

Biallelic PI4KA variants cause neurological, intestinal and immunological disease.

  • Author(s): Salter, Claire G;
  • Cai, Yiying;
  • Lo, Bernice;
  • Helman, Guy;
  • Taylor, Henry;
  • McCartney, Amber;
  • Leslie, Joseph S;
  • Accogli, Andrea;
  • Zara, Federico;
  • Traverso, Monica;
  • Fasham, James;
  • Lees, Joshua A;
  • Ferla, Matteo P;
  • Chioza, Barry A;
  • Wenger, Olivia;
  • Scott, Ethan;
  • Cross, Harold E;
  • Crawford, Joanna;
  • Warshawsky, Ilka;
  • Keisling, Matthew;
  • Agamanolis, Dimitris;
  • Ward Melver, Catherine;
  • Cox, Helen;
  • Elawad, Mamoun;
  • Marton, Tamas;
  • Wakeling, Matthew N;
  • Holzinger, Dirk;
  • Tippelt, Stephan;
  • Munteanu, Martin;
  • Valcheva, Deyana;
  • Deal, Christin;
  • Van Meerbeke, Sara;
  • Walsh Vockley, Catherine;
  • Butte, Manish J;
  • Acar, Utkucan;
  • van der Knaap, Marjo S;
  • Korenke, G Christoph;
  • Kotzaeridou, Urania;
  • Balla, Tamas;
  • Simons, Cas;
  • Uhlig, Holm H;
  • Crosby, Andrew H;
  • De Camilli, Pietro;
  • Wolf, Nicole I;
  • Baple, Emma L
  • et al.
Abstract

Phosphatidylinositol 4-kinase IIIα (PI4KIIIα/PI4KA/OMIM:600286) is a lipid kinase generating phosphatidylinositol 4-phosphate (PI4P), a membrane phospholipid with critical roles in the physiology of multiple cell types. PI4KIIIα's role in PI4P generation requires its assembly into a heterotetrameric complex with EFR3, TTC7 and FAM126. Sequence alterations in two of these molecular partners, TTC7 (encoded by TTC7A or TCC7B) and FAM126, have been associated with a heterogeneous group of either neurological (FAM126A) or intestinal and immunological (TTC7A) conditions. Here we show that biallelic PI4KA sequence alterations in humans are associated with neurological disease, in particular hypomyelinating leukodystrophy. In addition, affected individuals may present with inflammatory bowel disease, multiple intestinal atresia and combined immunodeficiency. Our cellular, biochemical and structural modelling studies indicate that PI4KA-associated phenotypical outcomes probably stem from impairment of PI4KIIIα-TTC7-FAM126's organ-specific functions, due to defective catalytic activity or altered intra-complex functional interactions. Together, these data define PI4KA gene alteration as a cause of a variable phenotypical spectrum and provide fundamental new insight into the combinatorial biology of the PI4KIIIα-FAM126-TTC7-EFR3 molecular complex.

Many UC-authored scholarly publications are freely available on this site because of the UC's open access policies. Let us know how this access is important for you.

Main Content
For improved accessibility of PDF content, download the file to your device.
Current View